Fundraising Fox
Hera Biotech
San Antonio, US · Founded 2020 · Delaware corporation · 6 known investors
Find your way into Hera Biotech
Sign up to see every warm intro you have to Hera Biotech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Hera Biotech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Hera Biotech develops diagnostics for women's health, aiming to detect conditions that legacy tools miss. Its platform is presented as AI-enabled and science-based, intended for clinical care settings.
Founders & leadership
Hera Biotech was founded in 2020 by Somer Baburek.
SB
Somer BaburekCo-Founder, CEO, PresidentSomer Baburek is an executive officer and director at Hera Biotech, which develops AI-enabled diagnostics for women's health conditions.
Board
PC
WS
Wendy SmithBoard director
NW
Neal Walsdorf, Jr.Board director
Investors · 6
Coyote Ventureslisted by Coyote VenturesSan Francisco
How we know: funding news · biospace.com · the VCSheet dataset · Not right? Tell us
Portfolialisted by PortfoliaSan Mateo
How we know: the VCSheet dataset · Not right? Tell us
Also in the syndicate · 3
Althea Group VenturesKendra Scott Women’s Entrepreneurial Leadership InstituteStella Angels
Funding
SEC filings, press & company announcements$4.8M disclosed across 4 of 5 rounds · 2020–2025
- $1.9Mseed financing roundAug 2022 · 2 sources
Althea Group Ventures, Coyote Ventures, Kendra Scott Women’s Entrepreneurial Leadership Institute, Stella Angels
Source ↗
▶$1.7MraisedSep 2026 · 26 investors · BiotechnologyRule 506(b)
▶$1.7MraisedSep 2026 · 26 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Somer BaburekExecutive Officer, Director
- Paul CastellaDirector
- Wendy SmithDirector
- Neal Walsdorf, Jr.Director
- Teo TijerinaDirector
- Offering amount
- $5M
- Amount sold
- $1.7M
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MofferedAug 2024 · BiotechnologyRule 506(b)
▶$6MofferedAug 2024 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul CastellaDirector
- Wendy SmithDirector
- Somer BaburekExecutive Officer, Director
- Neal Walsdorf, Jr.Director
- Offering amount
- $6M
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$260KraisedMay 2023 · 4 investors · BiotechnologyRule 506(b)
▶$260KraisedMay 2023 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Wendy SmithDirector
- Neal Walsdorf, Jr.Director
- Paul CastellaExecutive Officer, Director
- Somer BaburekExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $260K
- First sale
- May 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$853.5KraisedFeb 2022 · 19 investors · BiotechnologyRule 506(b)
▶$853.5KraisedFeb 2022 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul CastellaExecutive Officer, Director
- Neal Walsdorf, Jr.Director
- Wendy SmithDirector
- Somer BaburekExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $853.5K
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Hera Health SolutionsHera Health Solutions is a biotechnology company that develops a proprietary nanotechnology platform to reformulate existing pharmaceutical compounds into more effective and longer-acting therapies. The platform enables rapid optimization of drugs with improved release profiles, reduced toxicity, and scalable manufacturing.
Hera Women's HealthHera Women's Health partners with independent women's health providers to deliver clinical and operational support, modernizing practice operations while preserving physician independence and community relationships. The organization aims to improve healthcare delivery for women by removing administrative barriers and enabling providers to focus on patient care.
HeraHello Hera provides senior care coordination services delivered by human "Heroes" supported by AI, handling insurance, appointments, medication management, and other non-clinical care tasks for families with aging parents. The service is covered by Medicare, targeting families managing complex senior healthcare needs.
Hera BioLabsHera BioLabs provides gene editing technologies and cell line development services for drug discovery researchers. The company offers custom cell line platforms, animal models, and bioprocessing solutions using transposase technology and proprietary tools like the SRG Rat platform and CleanCut GS CHO system.
Companies working in the same space as Hera Biotech.
In the news
Frequently asked questions
- What does Hera Biotech do?
- Hera Biotech develops diagnostics for women's health, aiming to detect conditions that legacy tools miss. Its platform is presented as AI-enabled and science-based, intended for clinical care settings.
- Who founded Hera Biotech?
- Hera Biotech was founded by Somer Baburek in 2020.
- Who are Hera Biotech's investors?
- Hera Biotech's investors include Coyote Ventures, Portfolia, VentureDNA.
- How much funding has Hera Biotech raised?
- Hera Biotech has disclosed $4.8M raised across 4 of its 5 known rounds.
- Where is Hera Biotech headquartered?
- Hera Biotech is headquartered in San Antonio, US.